Disparity in Quality of Infectious Disease vs Addiction Care Among Patients With Injection Drug Use-Associated Staphylococcus aureus Bacteremia.
David Phillip SerotaEmily D NiehausMarcos C SchechterJesse T JacobJeb JonesSusan M RayColleen F KelleyRussell R KempkerPublished in: Open forum infectious diseases (2019)
Evidence-based interventions for Staphylococcus aureus bacteremia (SAB) are well known, but it is unclear how they are implemented among patients with injection drug use-associated (IDU) SAB. Of 46 patients with IDU-SAB identified, all received high-quality SAB management; however, few received appropriate recognition or treatment of their underlying substance use disorder.